Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease.

Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB.

Clin Pharmacol Ther. 2019 Oct;106(4):884-890. doi: 10.1002/cpt.1548. Epub 2019 Jul 17.

PMID:
31206613
2.

N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data.

Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Cai J, Wei X, Bazzan AJ, Zhong L, Bowen B, Intenzo CM, Iacovitti L, Newberg AB.

PLoS One. 2016 Jun 16;11(6):e0157602. doi: 10.1371/journal.pone.0157602. eCollection 2016.

3.

N-acetyl-cysteine in the treatment of Parkinson's disease. What are we waiting for?

Martínez-Banaclocha MA.

Med Hypotheses. 2012 Jul;79(1):8-12. doi: 10.1016/j.mehy.2012.03.021. Epub 2012 Apr 28.

PMID:
22546753

Supplemental Content

Loading ...
Support Center